Nvoy Strategies

Nvoy Strategies was a biotechnology company focused on developing a proprietary platform for the intracellular delivery of large, complex molecules, including proteins and antibodies. The company's core technology, known as the Nvoy platform, utilized a reversible chemical masking technique to protect therapeutic payloads from degradation and facilitate their transport across biological barriers. By temporarily neutralizing the charge and hydrophilicity of proteins, the platform aimed to enable the delivery of biologics to previously inaccessible intracellular targets. Nvoy Strategies was acquired by Absci in 2021 to integrate its delivery capabilities into Absci's synthetic biology and drug discovery engine.